Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Clairity is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Carrie Reeuwijk played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Clairity
At Clairity, we believe that everyone should know their risk of breast cancer and have access to life-saving screening technology. Clairitys mammography-based deep learning platform is revolutionizing the screening process by improving accuracy, eliminating bias, cultivating trust, reducing the cost of care and saving lives. Clairitys mission is grounded in the belief that everyone deserves to understand their health risks, regardless of race, ethnicity or gender. Within the domain of radiomics, advancements in AI unlock new insights from the data embedded in the image, accurately identifying those individuals who have the highest risk of developing cancer. These insights, in turn, enable clinicians to personalize a plan of care for each patient, and evolve that plan over time, monitoring lifestyle choices, changes in health, information regarding family history, and more.

To learn more about Clairity, visit http://clairity.com/

Contact:
Carrie Reeuwijk, Chief Executive Officer
512-721-1200
https://www.linkedin.com/in/carrie-ivers-reeuwijk-824692/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved